Invitation to General Meeting of Shareholders
The Board of Directors of Europlasma met today, as part of a warning procedure from its Statutory Auditors, to convene an Ordinary General Meeting to deliberate on the situation of the Company and the continuity of the operation.
Read the press release (in French)
Number of shares and voting rights as at 31/12/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.
Half-year report on liquidity contract as at 31/12/2018
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2018.
Update on funding prospects
As stated in the previous press release, Europlasma Group and its management are actively pursuing the objective of achieving a capital increase allowing the entry of a reference shareholder and thus ensuring the continuity of its operations.
Read the press release (in French)
Number of shares and voting rights as at 30/11/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November.
Suspension of the automatic issuance of the 4th warrant given access to convertible bonds
Europlasma has suspended, today, the 4th warrant given access to notes convertible into new shares (BEOCA).
Read the press release (in French)
Number of shares and voting rights as at 31/10/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.
Europlasma announces the reactivation of the financing agreement by issuance of convertible bonds
In the press release of September 3, 2018, Europlasma (the "Company") announced the suspension of the exercise of the third warrant given access to convertible bonds ("OCA") relating to the contract signed on July 17, 2018 (renewal of the contract concluded on February 9, 2018) with the Luxembourg fund European High Growth Opportunities Securitization Fund (the "Investor").
Read the press release (in French)
Number of shares and voting rights as at 30/09/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30 September.
Read the press release (in French)
General Meeting of Shareholders on 27 September 2018
- Quorum achieved: all resolutions suported by the Board of Directors have been approved
- Group's activity update